STOP HIV/AIDS®

Documents & Reports

HIV Monitoring Semi-Annual Report, Second Quarter 2024

HIV Monitoring Semi-Annual Report, Fourth Quarter 2023

HIV Monitoring Semi-Annual Report, Fourth Quarter 2022

HIV Monitoring Semi-Annual Report, Second Quarter 2022

HIV Monitoring Semi-Annual Report, Fourth Quarter 2021

Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025